Identification of Human SARS-CoV-2 Monoclonal Antibodies from Convalescent Patients Using EBV ImmortalizationArticle Published on 2021-07-052022-10-27 Journal: Antibodies [Category] COVID-19, [키워드] affected antibody sequence B cell clone clones COVID-19 infection Culture did not produce Donor EBV European functional Human identification in vitro Infection Isolation Italy lombardy mAb mAbs memory B cell monoclonal antibody Mutation Neutralizing activity pandemic positive purified recombinant proteins RNA SARS-CoV-2 SARS-CoV-2 isolates secreted sequenced Sequencing Spike protein supernatant tested the antibody the SARS-CoV-2 virus infection [DOI] 10.3390/antib10030026 PMC 바로가기 [Article Type] Article
Investigation of Long COVID Prevalence and Its Relationship to Epstein-Barr Virus ReactivationArticle Published on 2021-06-172022-10-28 Journal: Pathogens [Category] COVID-19, [키워드] Antigen association Asymptomatic COVID-19 Brain chronic COVID syndrome control subject coronavirus Coronavirus disease 2019 COVID COVID-19 COVID-19 patient determine disease EBV Epstein-Barr virus Epstein–Barr virus Epstein–Barr virus Epstein–Barr virus reactivation fatigue Fisher’s exact test IgG IgM Infection investigation Long Long COVID occur Occurrence PACS Patient positive Post-acute COVID-19 syndrome Prevalence Randomly rashes Reactivation recruited relationship SARS-CoV-2 study group subject Symptom Symptoms the SARS-CoV-2 virus with COVID-19 [DOI] 10.3390/pathogens10060763 PMC 바로가기 [Article Type] Article
The Status and Prospects of Epstein–Barr Virus Prophylactic Vaccine DevelopmentImmunology Published on 2021-06-082022-11-01 Journal: Frontiers in Immunology [Category] COVID-19, MERS, SARS, [키워드] adjuvant animal model Antigen Antiviral Autoimmune diseases B lymphocyte chronic disease Clinical use COVID-19 pandemic develop development disease Diseases EBV effective effort elicit epithelial cells Epstein–Barr virus Epstein–Barr virus expected Immunity improvement Infection malignancies malignancy management outbreak Prevent Primary infection Prophylactic SARS-CoV-2 status subsequent Vaccine Vaccine design Vaccine development virus immunology [DOI] 10.3389/fimmu.2021.677027 PMC 바로가기 [Article Type] Immunology
Hemophagocytic lymphohistiocytosis after COVID-19 vaccinationLetter to the Editor Published on 2021-06-042022-10-29 Journal: Journal of Hematology & Oncology [Category] COVID-19, MERS, SARS, [키워드] Acetate activated macrophage Bone marrow caused Chinese Coagulopathy coronavirus disease COVID-19 COVID-19 vaccination Critical Cytotoxic T cells cytotoxicity Dexamethasone discharged disorder DNA EBV elevated Epstein–Barr virus Epstein–Barr virus Fever fibrinogen first dose healthy hemoglobin hemophagocytic lymphohistiocytosis HLH Hyperinflammatory syndrome inactivated indicate Infection initial laboratory result life-threatening malaise multiple organ failure neutrophil count NK cell Platelet Positive test receiving reported resolved SARS-CoV-2 vaccine serum ferritin level SIGN the patient thrombotic Triglyceride Vaccine virus vomiting [DOI] 10.1186/s13045-021-01100-7 PMC 바로가기 [Article Type] Letter to the Editor
Positive Epstein–Barr virus detection in coronavirus disease 2019 (COVID-19) patients코로나바이러스 질병 2019(COVID-19) 환자에서 양성 엡스타인-바 바이러스 검출Article Published on 2021-05-252022-09-01 Journal: Scientific Reports [Category] SARS, 바이오마커, 진단, 치료기술, 치료법, [키워드] 95% CI Antigen aspartate Aspartate aminotransferase AST C-reactive protein C-reactive protein (CRP Capsid antigen Characteristics Coinfection coronavirus disease Coronavirus disease 2019 Corticosteroid COVID-19 COVID-19 patient COVID-19 patients detect EBV Epstein–Barr virus females Fever IgM antibody incidence Infection Infectious-disease diagnostics Inflammation median age Patient patients Renmin Hospital retrospective risk SARS-CoV-2 SARS-COV-2 infection serological result serological results seropositive severity of COVID-19 single-center study Symptom the SARS-CoV-2 two group two groups university viral capsid viral infection Wuhan [DOI] 10.1038/s41598-021-90351-y PMC 바로가기 [Article Type] Article
Case report: histopathology and molecular pathology analysis on enteric tissue of a COVID-19 patient증례보고: 코로나19 환자의 장 조직에 대한 조직병리학 및 분자병리학 분석Case Reports Published on 2021-05-052022-09-11 Journal: Diagnostic Pathology [Category] SARS, 바이오마커, 진단, 치료기술, [키워드] accompanied Analysis analyzed Antigen Case report CD3 CD4 CD68 Cell CMV cocci COVID-19 COVID-19 patient cytomegalovirus determined by distribution EBV enteric symptoms eosin examined Gastrointestinal infection Gram staining hematoxylin hematoxylin & eosin hemorrhage Herpe herpes simplex virus Histopathology immunohistochemistry In situ hybridization infiltration Inflammatory intestinal intestinal macrophage intestinal macrophages lymphocyte lymphocyte infiltration Lymphocytes Macrophage macrophages Methenamine Molecular pathology mucosal mucosal epithelium mycobacteria tuberculosis Necrosis neutrophil neutrophil infiltration overlapped PAS patient with COVID-19 performed Periodic positive proliferation Result RNA SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 RNA silver spore stain staining susceptibility tissue Tuberculosis with COVID-19 [DOI] 10.1186/s13000-021-01082-7 PMC 바로가기 [Article Type] Case Reports
High incidence of Epstein-Barr virus, cytomegalovirus, and human-herpes virus-6 reactivations in critically ill patients with COVID-19COVID-19가 있는 중환자에서 Epstein-Barr 바이러스, 거대 세포 바이러스 및 인간 헤르페스 바이러스-6 재활성화의 높은 발생률Observational Study Published on 2021-05-012022-09-11 Journal: Infectious diseases now [Category] Coronavirus, SARS, 임상, 치료기술, [키워드] admitted to ICU analysed CMV co-occurrence coronavirus disease COVID-19 Critically ill Critically ill patient cytomegalovirus develop EBV Epstein-Barr virus Epstein–Barr virus Epstein–Barr virus. Frequency herpesvirus herpesviruses HHV-6 ICU ICU admission incidence intensive care intensive care unit morbidity morbidity and mortality occur occurred Patient patients selected severe coronavirus disease systemic Viremia virus while with COVID-19 [DOI] 10.1016/j.idnow.2021.01.005 PMC 바로가기 [Article Type] Observational Study
Quantitative proteomics reveals a broad-spectrum antiviral property of ivermectin, benefiting for COVID-19 treatment정량적 단백질체학은 COVID-19 치료에 도움이 되는 이버멕틴의 광범위한 항바이러스 특성을 나타냅니다Article Published on 2021-04-012022-09-11 Journal: Journal of cellular physiology [Category] SARS, 유전자 메커니즘, 치료기술, 치료제, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 alteration Amino acid amino acids Analysis Antibacterial anticancer Antiviral biological processes Cancer cells Cell Cell culture cells cellular components complex coronavirus COVID-19 COVID-19 treatment cytokine Cytokines cytomegalovirus Diseases EBV Epstein-Barr virus G-protein Gene ontology Gene ontology analysis global public health growth factor HCMV Health HIV HIV1 HLA HPV Human Cytomegalovirus Human immunodeficiency virus human papillomavirus identify immunodeficiency virus IMPROVE in vitro Infection inhibit Interaction Ivermectin labeling molecular functions network analysis offer ovarian cancer papillomavirus pathway Pathways Personalized medicine PPI PPI network Predictive Protein Proteins proteomics Quantitative quantitative proteomics regulated Replication replication of SARS-CoV-2 reported reveal SARS-CoV-2/COVID-19 STABLE stable isotope labeling by amino acids in cell culture statistically significant treated Treatment virus virus infection virus-related pathways. was used [DOI] 10.1002/jcp.30055 PMC 바로가기 [Article Type] Article
Integrin Activation Enables Sensitive Detection of Functional CD4 + and CD8 + T Cells: Application to Characterize SARS-CoV-2 ImmunityImmunology Published on 2021-03-292022-11-01 Journal: Frontiers in Immunology [Category] COVID-19, SARS, [키워드] Activation acute respiratory syndrome Antigen antigen specificity applicability application CD154 CD4 CD4+ T cells CD8 CD8+ T cells cell type clone CMV conformational change coronavirus detection EBV Epstein–Barr virus Ex vivo fluorescent Frequency functional HBV Hepatitis B virus integrin activation intercellular Ligand marker memory MONITOR monoclonal antibody mononuclear cell PBMCs Peripheral blood protocol SARS-CoV-2 sensitive shown T cell T cell responses T cells vaccinated individuals vaccination Whole blood [DOI] 10.3389/fimmu.2021.626308 PMC 바로가기 [Article Type] Immunology
Case Report: Severe COVID-19 Pneumonia in a Patient With Relapsed/Refractory Hodgkin’s LymphomaOncology Published on 2021-03-182022-10-31 Journal: Frontiers in Oncology [Category] COVID-19, [키워드] acute respiratory distress adverse outcome Allogeneic allogeneic stem cell ARDS autologous brentuximab Cancer Chemotherapy China coronavirus disease Coronavirus disease 2019 COVID-19 diagnosed Donor donor lymphocyte infusion EBV Effect expected global pandemic graft-versus-host-disease GVHD haematological malignancy Hodgkin’s lymphoma Immunosuppression lymphocyte lymphoma lymphoproliferative disease multiorgan failure Patient reported risk Severe COVID-19 pneumonia Stem cell transplantation suffered syndrome therapy treated viral infection [DOI] 10.3389/fonc.2021.601709 PMC 바로가기 [Article Type] Oncology